Related Experiment Videos
Functional characterization of five constitutively activating thyrotrophin receptor mutations
1Medizinische Klinik und Poliklinik III, Universität Leipzig, Leipzig, Germany.
Clinical Endocrinology
|September 30, 2000
Summary
Gain of function mutations in the thyrotrophin receptor (TSHR) were studied. A deletion mutant showed constitutive activity for both cAMP and inositol phosphate pathways, suggesting different TSHR active conformations.
Area of Science:
- Endocrinology
- Molecular Biology
- Cell Signaling
Background:
- Gain of function mutations in the thyrotrophin receptor (TSHR) alter receptor function, impacting cAMP and inositol phosphate (IP) accumulation, cell surface expression, and TSH affinity.
- Understanding these mutations is crucial for elucidating TSHR signaling pathways and associated thyroid disorders.
Purpose of the Study:
- To compare the functional characteristics of five constitutively activating TSHR mutations, including four point mutations and one deletion mutant.
- To investigate the effects of these mutations on cAMP and IP accumulation, cell surface expression, and TSHR regulation.
Main Methods:
- Transiently expressed wild-type TSHR and mutant TSHRs (S505N, L629F, I630L, V656F, and deletion 613-621) in COS-7 cells.
- Assessed basal and stimulated cAMP and IP accumulation, cell surface expression (FACS, ELISA), and TSHR downregulation post-transfection.
Main Results:
- Despite varying specific constitutive activity and cell surface expression levels, basal cAMP accumulation was uniform across mutants.
- Point mutations did not constitutively activate the phospholipase C cascade, whereas the deletion mutant (613-621) exhibited constitutive IP pathway activity.
- All mutants showed TSH-stimulated receptor downregulation, independent of the phospholipase C pathway.
Conclusions:
- Uniform basal cAMP levels suggest regulation within the COS-7 overexpression system, likely due to receptor downregulation.
- The TSHR deletion mutant (613-621) displayed constitutive activity in both Galphas and Galphaq/11 pathways.
- The contrasting responses to TSH for cAMP and IP accumulation in the deletion mutant support the model of distinct TSHR active conformations.